You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Mantle-Cell
  • Paris Cedex 13, France
    (unnamed)
2022-03-24
Mar 24, 2022
B
Not yet recruiting
  • Lymphoma
  • +4 more
  • IM19 CAR-T cells
  • +2 more
  • (no location specified)
2021-11-30
Nov 30, 2021
C
Active, not recruiting
  • Lymphoma, Mantle-Cell
  • Recurrent Lymphoma, Mantle-Cell
  • ABT-199 and Ibrutinib Combination
  • Duarte, California
  • +3 more
2021-01-06
Jan 6, 2021
A
Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
2021-07-19
Jul 19, 2021
C
Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Polatuzumab vedotin
  • +2 more
  • Brno, Czechia
  • +6 more
2021-05-28
May 28, 2021
W
Terminated
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
2021-09-20
Sep 20, 2021
U
Not yet recruiting
  • Mantle Cell Lymphoma
  • (no location specified)
2021-08-04
Aug 4, 2021
N
Completed
  • Mantle Cell Lymphoma
  • Lymphoma, Mantle Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-24
Mar 24, 2022
A
Enrolling by invitation
  • Lymphoma, Follicular
  • +7 more
  • ADI-001
  • Stanford, California
  • +4 more
2021-08-26
Aug 26, 2021
Z
Active, not recruiting
  • Mantle Cell Lymphoma
  • Beijing, China
    Peking University Cancer Hospital
2021-08-18
Aug 18, 2021
U
Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2022-03-07
Mar 7, 2022
J
Active, not recruiting
  • Follicular Lymphomas
  • +5 more
  • Giessen, Germany
    StiL Head Office; Justus-Liebig-University
2021-04-28
Apr 28, 2021
A
Recruiting
  • Lymphoma, Follicular
  • +7 more
  • ADI-001
  • +4 more
  • Stanford, California
  • +4 more
2021-08-26
Aug 26, 2021
H
Recruiting
  • Mantle Cell Lymphoma
  • Busan, Western, Korea, Republic of
    Kosin University Gospel Hospital
2022-03-31
Mar 31, 2022
N
Suspended
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
E
Recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Miami, Florida
  • +4 more
2022-03-07
Mar 7, 2022
T
Recruiting
  • Lymphoma
  • +6 more
  • Gilbert, Arizona
  • +6 more
2021-03-29
Mar 29, 2021
B
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • LUCAR-20S CAR-T cells
  • Beijing, Beijing, China
    Beijing Boren Hospital
2021-08-05
Aug 5, 2021
C
Recruiting
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Determination of COVID-19 vacciantion efficacy
  • Rouen, France
    Centre Henri Becquerel
2021-06-07
Jun 7, 2021
T
Recruiting
  • Mantle Cell Lymphoma
  • Orelabrutinib in in combination of rituximab and lenalidomide(OLR)
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
2021-11-03
Nov 3, 2021
W
Recruiting
  • Mantle Cell Lymphoma
  • Ketogenic Dieting
  • Ketogenic Diet
  • New York, New York
    Weill Cornell Medicine
2021-07-27
Jul 27, 2021
U
Active, not recruiting
  • Mantle-Cell Lymphoma
  • G-CSF
  • +10 more
  • Miami, Florida
    University of Miami
2021-08-12
Aug 12, 2021
W
Recruiting
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
2021-10-29
Oct 29, 2021
K
Not yet recruiting
  • Mantle Cell Lymphoma
  • RB/RBAC alternating
  • RB
  • Seoul, Gangnam-Gu, Korea, Republic of
    Samsung Medical Center
2022-02-08
Feb 8, 2022